Todd Skaar

  • 7073 Citations
  • 39 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Todd Skaar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Cytochrome P-450 CYP2D6 Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Pharmacogenetics Medicine & Life Sciences
Genotype Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
exemestane Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 2009 2019

RNA Precursors
Protein Splicing
Messenger RNA
Paclitaxel
Computational Biology
Precision Medicine
Costs and Cost Analysis
Health
Vulnerable Populations
Pharmacogenetics
Drug and Narcotic Control
MicroRNAs
Enzymes
Pharmaceutical Preparations
Cytochrome P-450 Enzyme System

Publications 1989 2019

  • 7073 Citations
  • 39 h-Index
  • 157 Article
  • 1 Review article

Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology

Swart, M., Stansberry, W. M., Pratt, V. M., Medeiros, E. B., Kiel, P. J., Shen, F., Schneider, B. & Skaar, T., May 1 2019, In : Journal of Molecular Diagnostics. 21, 3, p. 491-502 12 p.

Research output: Contribution to journalArticle

Genotype
Therapeutics
Validation Studies
Pharmacogenetics
Practice Guidelines
1 Citation (Scopus)

Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy

Collins, K. S., Pratt, V. M., Stansberry, W. M., Medeiros, E. B., Kannegolla, K., Swart, M., Skaar, T., Chapman, A. B., Decker, B., Moorthi, R. & Eadon, M., Jan 1 2019, In : Pharmacogenetics and Genomics. 29, 1, p. 18-22 5 p.

Research output: Contribution to journalArticle

Chronic Renal Insufficiency
Antihypertensive Agents
Hypertension
Disease Progression
Kidney Diseases

Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial

Fulton, C. R., Zang, Y., Desta, Z., Rosenman, M., Holmes, A., Decker, B., Zhang, Y., T Callaghan, J., Pratt, V. M., Levy, K., Gufford, B. T., Dexter, P. R., Skaar, T. & Eadon, M., Apr 1 2019, In : Pharmacogenomics. 20, 6, p. 397-408 12 p.

Research output: Contribution to journalArticle

Tramadol
Codeine
Drug Interactions
Cytochrome P-450 CYP2D6
Pharmaceutical Preparations

Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole

Dempsey, J. M., Kidwell, K. M., Gersch, C. L., Pesch, A. M., Desta, Z., Storniolo, A. M., Stearns, V., Skaar, T., Hayes, D. F., Henry, N. L., Rae, J. M. & Hertz, D. L., Jan 1 2019, In : Pharmacogenomics. 20, 8, p. 571-580 10 p.

Research output: Contribution to journalArticle

exemestane
letrozole
Aromatase Inhibitors
Estrogens
Breast Neoplasms
1 Citation (Scopus)

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing

on behalf of the IGNITE Network, Jan 1 2019, In : Genetics in Medicine.

Research output: Contribution to journalArticle

Drug Prescriptions
Cytochrome P-450 CYP2D6
Genotype
Clinical Decision Support Systems
Pharmacogenetics